An Uphill Battle
With short lives and uncertain profits, antibiotics are a unique development challenge for drug companies
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
April 14, 2008 Cover
Volume 86, Issue 15
With short lives and uncertain profits, antibiotics are a unique development challenge for drug companies
Credit:
With short lives and uncertain profits, antibiotics are a unique development challenge for drug companies
Microbial meteorologists investigate how airborne microbes might influence weather
House committee probe of industry bias in agency review reaches former ACS president
The science that gives clothing a soft feel and fresh scent as it prevents static cling
Rising prices for sulfuric acid have widespread industrial impact
Economic slowdown, job dip, and changing world economy should bring critical analysis of the outlook for the domestic workforce